Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C F Moore

Showing results (91-100 of 168) with videos related to

Pageof 17
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2006
An open-label, fixed-dose study of bupropion effect on sexual function scores in women treated for breast cancerC Mathias, C M Cardeal Mendes, E Pondé de Sena, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2023
Open-label, phase II, multicenter study of lasofoxifene plus abemaciclib for treating women with metastatic ER+/HER2- breast cancer and an ESR1 mutation after disease progression on prior therapies: ELAINE 2S Damodaran, C C O'Sullivan, A Elkhanany, et al.
Cancer|March 15, 2022
A randomized controlled trial of the effect of supervised exercise on functional outcomes in older African American and non-Hispanic White breast cancer survivors: Are there racial differences in the effects of exercise on functional outcomes?Cynthia Owusu, Seunghee Margevicius, Nora L Nock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2007
Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer: Southwest Oncology Group/Intergroup study 9623Halle C F Moore, Stephanie J Green, Julie R Gralow, et al.
Cancer|February 4, 2021
IMPROVE, a community-based exercise intervention versus support group to improve functional and health outcomes among older African American and Non-Hispanic White breast cancer survivors from diverse socioeconomic backgrounds: Recruitment strategies and baseline characteristicsCynthia Owusu, Nora L Nock, Vanessa Feuntes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2021
A Randomized Trial of Fulvestrant, Everolimus, and Anastrozole for the Front-line Treatment of Patients with Advanced Hormone Receptor-positive Breast Cancer, SWOG S1222Halle C F Moore, William E Barlow, George Somlo, et al.
Breast Cancer Research and Treatment|January 12, 2013
Supplement use during an intergroup clinical trial for breast cancer (S0221)Gary R Zirpoli, Patrick M Brennan, Chi-Chen Hong, et al.
Journal of the National Cancer Institute|March 17, 2018
Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP StudyGary R Zirpoli, Susan E McCann, Lara E Sucheston-Campbell, et al.
JNCI Cancer Spectrum|March 15, 2026
Long-Term follow-up of S0221, comparing alternative Dose-Schedules of anthracycline/taxane therapy in early breast cancerAzka Ali, William E Barlow, Halle C F Moore, et al.
Breast Cancer Research : BCR|November 30, 2018
Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)Jennifer M Mongiovi, Gary R Zirpoli, Rikki Cannioto, et al.
Pageof 17

Showing results (91-100 of 168) with videos related to

Sort By:
Pageof 17
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2006
An open-label, fixed-dose study of bupropion effect on sexual function scores in women treated for breast cancerC Mathias, C M Cardeal Mendes, E Pondé de Sena, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2023
Open-label, phase II, multicenter study of lasofoxifene plus abemaciclib for treating women with metastatic ER+/HER2- breast cancer and an ESR1 mutation after disease progression on prior therapies: ELAINE 2S Damodaran, C C O'Sullivan, A Elkhanany, et al.
Cancer|March 15, 2022
A randomized controlled trial of the effect of supervised exercise on functional outcomes in older African American and non-Hispanic White breast cancer survivors: Are there racial differences in the effects of exercise on functional outcomes?Cynthia Owusu, Seunghee Margevicius, Nora L Nock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2007
Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer: Southwest Oncology Group/Intergroup study 9623Halle C F Moore, Stephanie J Green, Julie R Gralow, et al.
Cancer|February 4, 2021
IMPROVE, a community-based exercise intervention versus support group to improve functional and health outcomes among older African American and Non-Hispanic White breast cancer survivors from diverse socioeconomic backgrounds: Recruitment strategies and baseline characteristicsCynthia Owusu, Nora L Nock, Vanessa Feuntes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2021
A Randomized Trial of Fulvestrant, Everolimus, and Anastrozole for the Front-line Treatment of Patients with Advanced Hormone Receptor-positive Breast Cancer, SWOG S1222Halle C F Moore, William E Barlow, George Somlo, et al.
Breast Cancer Research and Treatment|January 12, 2013
Supplement use during an intergroup clinical trial for breast cancer (S0221)Gary R Zirpoli, Patrick M Brennan, Chi-Chen Hong, et al.
Journal of the National Cancer Institute|March 17, 2018
Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP StudyGary R Zirpoli, Susan E McCann, Lara E Sucheston-Campbell, et al.
JNCI Cancer Spectrum|March 15, 2026
Long-Term follow-up of S0221, comparing alternative Dose-Schedules of anthracycline/taxane therapy in early breast cancerAzka Ali, William E Barlow, Halle C F Moore, et al.
Breast Cancer Research : BCR|November 30, 2018
Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)Jennifer M Mongiovi, Gary R Zirpoli, Rikki Cannioto, et al.
Pageof 17